We are live on ! Find out more
NHC

Nicholas Hoffman & Company Portfolio holdings

AUM $4.33B
1-Year Est. Return 18.98%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+18.98%
3 Year Est. Return
+55.21%
5 Year Est. Return
+46.72%
10 Year Est. Return
+185.29%
AUM
$2.37B
AUM Growth
+$239M
Cap. Flow
+$84.6M
Cap. Flow %
3.57%
Top 10 Hldgs %
75.08%
Holding
301
New
16
Increased
109
Reduced
116
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 7.31%
2 Financials 7.24%
3 Consumer Staples 1.89%
4 Healthcare 1.61%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSN icon
226
Tyson Foods
TSN
$20.4B
$394K 0.02%
6,610
+1,000
+18% +$61K
RY icon
227
Royal Bank of Canada
RY
$291B
$381K 0.02%
3,051
CB icon
228
Chubb
CB
$135B
$373K 0.02%
1,295
-31
-2% -$8.5K
SPDW icon
229
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.2B
$368K 0.02%
9,808
FCX icon
230
Freeport-McMoran
FCX
$90B
$368K 0.02%
7,365
-1,600
-18% -$72.1K
BN icon
231
Brookfield
BN
$104B
$359K 0.02%
10,137
-35
-0.3% -$1.1K
BP icon
232
BP
BP
$116B
$354K 0.01%
11,289
+172
+2% +$5.82K
VONV icon
233
Vanguard Russell 1000 Value ETF
VONV
$20.7B
$354K 0.01%
4,247
HDV
234
iShares Core High Dividend ETF
HDV
$14.5B
$352K 0.01%
14,970
+80
+0.5% +$1.83K
BSV icon
235
Vanguard Short-Term Bond ETF
BSV
$44.7B
$351K 0.01%
4,465
+100
+2% +$7.79K
VRTX icon
236
Vertex Pharmaceuticals
VRTX
$121B
$340K 0.01%
732
-100
-12% -$48K
JCI icon
237
Johnson Controls International
JCI
$88.8B
$339K 0.01%
4,362
+48
+1% +$3.37K
DEO icon
238
Diageo
DEO
$49B
$338K 0.01%
2,410
+15
+0.6% +$1.95K
NKE icon
239
Nike
NKE
$61.9B
$337K 0.01%
3,808
-188
-5% -$14.7K
RF icon
240
Regions Financial
RF
$26.4B
$337K 0.01%
14,424
GPN icon
241
Global Payments
GPN
$23B
$336K 0.01%
+3,277
New +$340K
AMGN icon
242
Amgen
AMGN
$208B
$333K 0.01%
1,033
+195
+23% +$63.8K
LHX icon
243
L3Harris
LHX
$51.6B
$322K 0.01%
1,353
+43
+3% +$9.93K
BX icon
244
Blackstone
BX
$102B
$316K 0.01%
2,061
GSBD icon
245
Goldman Sachs BDC
GSBD
$969M
$314K 0.01%
22,846
+16
+0.1% +$232
IEFA icon
246
iShares Core MSCI EAFE ETF
IEFA
$190B
$312K 0.01%
3,993
FISV
247
Fiserv Inc
FISV
$28.8B
$306K 0.01%
1,704
MGV icon
248
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
$305K 0.01%
2,377
PJP icon
249
Invesco Pharmaceuticals ETF
PJP
$442M
$302K 0.01%
3,475
MAR icon
250
Marriott International
MAR
$98.3B
$300K 0.01%
1,208
+1
+0.1% +$233

Similar funds

Nicholas Hoffman & Company's Q3 2024 Portfolio in Review

As of Q3 2024, Nicholas Hoffman & Company held 301 positions worth $2.37B, up 11% from $2.13B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Nicholas Hoffman & Company deployed $84.6M of net new capital in Q3 2024, opening 16 new positions and adding to 109 existing holdings. Its largest new stake was Zimmer Biomet: 9,844 shares worth $1.06M.

By sector, the portfolio is most concentrated in Technology at 7.3% of assets, down from 7.8% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.85M trimmed.

  • Nicholas Hoffman & Company's largest Q3 2024 buy was Zimmer Biomet: 9,844 shares worth $1.06M.
  • Nicholas Hoffman & Company added most to Vanguard S&P 500 ETF in Q3 2024, an estimated $26.7M increase.
  • Nicholas Hoffman & Company's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.85M.
  • Nicholas Hoffman & Company fully exited Novo Nordisk in Q3 2024, selling an estimated $496K.
  • Nicholas Hoffman & Company's ten largest holdings make up 75% of its $2.37B portfolio in Q3 2024.
  • Nicholas Hoffman & Company opened 16 new positions and closed 10 in Q3 2024.
  • Nicholas Hoffman & Company's portfolio value rose 11% quarter-over-quarter to $2.37B.

Based on Nicholas Hoffman & Company's 13F filing for Q3 2024, filed 25 Oct 2024.